Trial · NCT01986933
Adverse event totals27
The totals the trial posted for each group.
1 to 20 of 27
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Placebo (Part A) | 0 | 53 |
| Total, all-cause mortality | Nemoliozumab (0.1 mg/kg) Q4W (Part A) | 0 | 53 |
| Total, all-cause mortality | Nemoliozumab (0.5 mg/kg) Q4W (Part A) | 0 | 54 |
| Total, all-cause mortality | Nemoliozumab (2.0 mg/kg) Q4W (Part A) | 0 | 52 |
| Total, all-cause mortality | Nemoliozumab (2.0 mg/kg) Q8W (Part A) | 0 | 52 |
| Total, all-cause mortality | Nemoliozumab (0.1 mg/kg) Q4W (Part A + Part B) | 0 | 53 |
| Total, all-cause mortality | Nemoliozumab (0.5 mg/kg) Q4W (Part A + Part B) | 0 | 54 |
| Total, all-cause mortality | Nemoliozumab (2.0 mg/kg) Q4W (Part A + Part B) | 0 | 52 |
| Total, all-cause mortality | Nemoliozumab (2.0 mg/kg) Q8W (Part A + Part B) | 0 | 52 |
| Total, other adverse events | Placebo (Part A) | 27 | 53 |
| Total, other adverse events | Nemoliozumab (0.1 mg/kg) Q4W (Part A) | 29 | 53 |
| Total, other adverse events | Nemoliozumab (0.5 mg/kg) Q4W (Part A) | 23 | 54 |
| Total, other adverse events | Nemoliozumab (2.0 mg/kg) Q4W (Part A) | 27 | 52 |
| Total, other adverse events | Nemoliozumab (2.0 mg/kg) Q8W (Part A) | 25 | 52 |
| Total, other adverse events | Nemoliozumab (0.1 mg/kg) Q4W (Part A + Part B) | 37 | 53 |
| Total, other adverse events | Nemoliozumab (0.5 mg/kg) Q4W (Part A + Part B) | 35 | 54 |
| Total, other adverse events | Nemoliozumab (2.0 mg/kg) Q4W (Part A + Part B) | 33 | 52 |
| Total, other adverse events | Nemoliozumab (2.0 mg/kg) Q8W (Part A + Part B) | 35 | 52 |
| Total, serious adverse events | Placebo (Part A) | 1 | 53 |
| Total, serious adverse events | Nemoliozumab (0.1 mg/kg) Q4W (Part A) | 1 | 53 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01986933/event-totals